Women’s Health & OB/GYN News

The U.S. Preventive Services Task Force released a draft recommendation encouraging physicians to provide counseling that supports breastfeeding to people who are pregnant or who recently gave birth.

DENVER — For women with polycystic ovary syndrome and overweight or obesity, neither oral contraceptive pills nor metformin altered the characteristic markers of metabolic syndrome, either alone or in combination, researchers reported.

DENVER — In a survey of U.S. medical trainees, many respondents reported concerns about their or their partner’s future fertility and expressed interest in oocyte cryopreservation, but were unaware of available treatment options.

BOSTON — Adolescent mothers with pre-pregnancy depression were at higher risk for e-cigarette and cigarette use during late pregnancy vs. those without pre-pregnancy depression, according to data presented at the CHEST Annual Meeting.

DENVER — The top-viewed TikTok videos about polycystic ovary syndrome often contain unreliable or misleading medical information, with fewer than 4% of videos created by physicians or other medical professionals, data show.

DENVER — Most oocyte donors remain positive about the decision to donate and report a willingness for future contact with the children born from donations, whereas some expressed health and fertility concerns after donating, data show.

DENVER — Providing mail-in testing for infertility workup improved time to completion of semen analysis compared with traditional testing in a fertility clinic, according to data presented at the ASRM Scientific Congress & Expo.

Adults without health insurance in the United States reported they did not have a routine medical visit or cancer screening in the past year, new survey data showed.

DENVER — Exposure to testosterone therapy did not impact outcomes related to egg freezing for transgender men who sought fertility preservation treatment, researchers reported.

DENVER — A prediction model that integrates machine learning-derived measures of ovarian volume, anti-Müllerian hormone levels and other clinically-derived diagnostic endpoints accurately predicted polycystic ovary syndrome.